Dihydromyricetin Inhibits M1 Macrophage Polarization in Atherosclerosis by Modulating miR-9-Mediated SIRT1/NF-κB Signaling Pathway

Figure 1

(a–c) qPCR analysis of the expression of M1/M2 markers in the tissues between the vehicle control () and DMY () groups. (d–i) qPCR verification M1/M2 marker expression in LPS-induced BMDMs with/without DMY treatment (). , , and .

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)